Recognizing and managing severe sepsis: A common and deadly threat

Southern Medical Journal

Volumn 100, Issue 6, 2007, Pages 594-600

  Schlichting, Douglas ^a   McCollam, Jill Shwed ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

ICU; Severe sepsis; Treatment guidelines

Indexed keywords

ANTIBIOTIC AGENT; DROTRECOGIN; HYPERTENSIVE FACTOR; STEROID;

ARTIFICIAL VENTILATION; BLOOD CLOTTING; CLINICAL FEATURE; ENDOTHELIAL DYSFUNCTION; FIBRINOLYSIS; HUMAN; HYPOTENSION; INFLAMMATION; LOW DRUG DOSE; MICROVASCULAR ISCHEMIA; MORTALITY; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY; RESUSCITATION; REVIEW; SEPSIS; SEPTIC SHOCK;

CLINICAL PROTOCOLS; EUROPE; EVIDENCE-BASED MEDICINE; HUMANS; INTERNATIONAL COOPERATION; PRACTICE GUIDELINES; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UNITED STATES;

EID: 34250715349     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e31804aa29f     Document Type: Review

References (52)

1. Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-873.
2. Bone RC, Balk R, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-1655.
3. Bernard GR, Vincent JL, Laterre PR, et al. Efficacy and safety of recombinant human activated protein c for severe sepsis. N Engl J Med 2001;344:699-709.
4. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-1310.
5. Hoyert DL, Heron MP, Murphy SL, et al. Deaths: final data for 2003. Natl Vital Stat Rep 2006;54:13.
6. American Cancer Society. Breast cancer facts and figures 2005-2006. American Cancer Society 2006.
7. American Cancer Society. Colorectal cancer facts and figures special edition 2005. American Cancer Society 2005.
8. American Heart Association. Heart disease and stroke statistics - 2005 update. American Heart Association 2005.
9. Sands KE, Bates DW, Lanken PN, et al. Epidemiology of sepsis syndrome in 8 academic medical centers: Academic Medical Center Consortium Sepsis Project Working Group. JAMA 1997;278:234-240.
10. Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-1554.
11. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999;340:207-214.
12. Friedman G, Silva E, Vincent JL. Has the mortality of septic shock changed with time. Crit Care Med 1998;26:2078-2086.
13. Bone RC, Fisher CJ Jr, Clemmer TP, et al. Sepsis syndrome: a valid clinical entity: Methylprednisolone Severe Sepsis Study Group. Crit Care Med 1989;17:389-393.
14. Bernard GR, Vincent J-L, Laterre P-F, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709.
15. Abraham E, Naum C, Bandi V, et al. Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failure. Crit Care Med 2003;31:718-728.
16. Abraham E, Reinhart K, Opal S, et al. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 2003;290:238-247.
17. Rangel-Frausto MS, Pittet D, Costigan M, et al. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 1995;273:117-123.
18. Kleinpell RM. The role of the critical care nurse in the assessment and management of the patient with severe sepsis. Crit Care Nurs Clin North Am 2003;15:27-34.
19. Balk RA. Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock. Crit Care Clin 2000;16:337-352.
20. Opal SM, Esmon CT. Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit Care 2003;7:23-38.
21. Weyand CM, Goronzy JJ. The innate and adaptive immune systems. Cecil Textbook of Medicine. Goldman L, Ausiello D (eds). Philadelphia, Saunders, 2004 , pp 208-211.
22. Lien E, Ingalls RR. Toll-like receptors. Crit Care Med 2002;30:S1-S11.
23. Gibot S. Fighting the enemy properly? Crit Care Med 2004;32:1223-1224.
24. Heinzelmann M, Scott M, Lam T. Factors predisposing to bacterial invasion and infection. Am J Surg 2002;183:179-190.
25. Boxer LA. Disorders of Phagocyte Function. Cecil Textbook of Medicine. Goldman L, Ausiello D (eds). Philadelphia, Saunders, 2004, pp1088-1089.
26. Aird WC. Endothelial cell heterogeneity. Crit Care Med 2003;31:S221-S230.
27. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003;101:3765-3777.
28. Joyce DE, Nelson DR, Grinnell BW. Leukocyte and endothelial cell interactions in sepsis: relevance of the protein C pathway. Crit Care Med 2004;32:S280-S286.
29. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 2000;407:258-264.
30. Bateman RM, Sharpe MD, Ellis CG. Bench-to-bedside review: microvascular dysfunction in sepsis: hemodynamics, oxygen transport, and nitric oxide. Crit Care 2003;7:359-373.
31. Nimah M, Brilli RJ. Coagulation dysfunction in sepsis and multiple organ system failure. Crit Care Clin 2003;19:441-458.
32. Levi M, Ten Cate H, Van der PT. Endothelium: interface between coagulation and inflammation. Crit Care Med 2002;30:S220-S224.
33. Schleef RR, Loskutoff DJ. Fibrinolytic system of vascular endothelial cells: role of plasminogen activator inhibitors. Haemostasis 1988;18:328-341.
34. Aird WC. Endothelium as an organ system. Crit Care Med 2004;32:S271-S279.
35. Hack CE, Zeerleder S. The endothelium in sepsis: source of and a target for inflammation. Crit Care Med 2001;29:S21-S27.
36. Garcia JG. Molecular mechanisms of thrombin-induced human and bovine endothelial cell activation. J Lab Clin Med 1992;120:513-519.
37. Lopez-Aguirre Y, Paramo JA. Endothelial cell and hemostatic activation in relation to cytokines in patients with sepsis. Thromb Res 1999;94:95-101.
38. Mutunga M, Fulton B, Bullock R, et al. Circulating endothelial cells in patients with septic shock. Am J Respir Crit Care Med 2001;163:195-200.
39. Ince C. Microcirculation in distress: a new resuscitation end point? Crit Care Med 2004;32:1963-1964.
40. Ince C, Sinaasappel M. Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med 1999;27:1369-1377.
41. De Backer D, Creteur J, Preiser JC, et al. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002;166:98-104.
42. Sakr Y, Dubois MJ, De Backer D, et al. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock [see comment]. Crit Care Med 2004;32:1825-1831.
43. Balk RA. Severe sepsis and septic shock: definitions, epidemiology, and clinical manifestations. Crit Care Clin 2000;16:179-192.
44. Balk RA. Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations. Dis Mon 2004;50:168-213.
45. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med 2001;29:S109-S116.
46. Sakr Y, Dubois MJ, De Backer D, et al. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004;32:1825-1831.
47. Vincent JL, de Mendonca A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study: Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine [see comment]. Crit Care Med 1998;26:1793-1800.
48. IHI: Severe Sepsis Bundles. Institute for Healthcare Improvement 2005. Available at: http://www.ihi.org/ihi. Accessed January 25, 2007.
49. Levy MM, Pronovost PJ, Dellinger RP, et al. Sepsis change bundles: converting guidelines into meaningful change in behavior and clinical outcome. Crit Care Med 2004;32:S595-S597.
50. Gao F, Melody T, Daniels D, et al. The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study. Crit Care 2005;9:R764-R770.
51. Micek ST, Roubinian N, Heuring T, et al. Before-after study of a standardized hospital order set for the management of septic shock. Crit Care Med 2006;34:2707-2713.
52. Sebat F, Johnson D, Musthafa AA, et al. A multidisciplinary community hospital program for early and rapid resuscitation of shock in nontrauma patients. Chest 2005;127:1729-1743.